Search research articles
Contact Us
Filters
Showing results (181-190 of 214) with videos related to
Page
of 22
Sort By:
European Journal of Pharmacology
|
February 7, 2012
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice
Sarah E Snider, Sarah A Vunck, Edwin J C G van den Oord, et al.
Neuropharmacology
|
March 11, 2022
NLX-112, a highly selective 5-HT<sub>1A</sub> receptor biased agonist, does not exhibit misuse potential in male rats or macaques
R Depoortère, J Bergman, P M Beardsley, et al.
Journal of Medicinal Chemistry
|
August 7, 1992
Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions
N S Chandrakumar, A Stapelfeld, P M Beardsley, et al.
Drug and Alcohol Dependence
|
January 16, 2022
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats
Colleen Synan, Carrie Bowen, David J Heal, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 9, 2015
Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration
Joseph L McClay, Sarah A Vunck, Angela M Batman, et al.
Pharmacology, Biochemistry, and Behavior
|
June 4, 2024
Characterization and validation of a spontaneous acute and protracted oxycodone withdrawal model in male and female mice
Katherine M Contreras, Belle Buzzi, Julian Vaughn, et al.
Biochemical Pharmacology
|
October 21, 2021
Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated
Neil B Varshneya, Sherif H Hassanien, Melissa C Holt, et al.
Archives of Physical Medicine and Rehabilitation
|
December 23, 1998
Neuropathic pain in Charcot-Marie-Tooth disease
G T Carter, M P Jensen, B S Galer, et al.
Pharmacology, Biochemistry, and Behavior
|
May 26, 2023
Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression
Neil B Varshneya, Sherif H Hassanien, Melissa C Holt, et al.
The American Journal of Drug and Alcohol Abuse
|
December 1, 2001
Residential status and HIV risk behaviors among Puerto Rican drug injectors in New York and Puerto Rico
J F Andía, S Deren, S Y Kang, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 214) with videos related to
Sort By:
Page
of 22
European Journal of Pharmacology
|
February 7, 2012
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice
Sarah E Snider, Sarah A Vunck, Edwin J C G van den Oord, et al.
Neuropharmacology
|
March 11, 2022
NLX-112, a highly selective 5-HT<sub>1A</sub> receptor biased agonist, does not exhibit misuse potential in male rats or macaques
R Depoortère, J Bergman, P M Beardsley, et al.
Journal of Medicinal Chemistry
|
August 7, 1992
Analogs of the delta opioid receptor selective cyclic peptide [2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions
N S Chandrakumar, A Stapelfeld, P M Beardsley, et al.
Drug and Alcohol Dependence
|
January 16, 2022
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in rats
Colleen Synan, Carrie Bowen, David J Heal, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
April 9, 2015
Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration
Joseph L McClay, Sarah A Vunck, Angela M Batman, et al.
Pharmacology, Biochemistry, and Behavior
|
June 4, 2024
Characterization and validation of a spontaneous acute and protracted oxycodone withdrawal model in male and female mice
Katherine M Contreras, Belle Buzzi, Julian Vaughn, et al.
Biochemical Pharmacology
|
October 21, 2021
Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated
Neil B Varshneya, Sherif H Hassanien, Melissa C Holt, et al.
Archives of Physical Medicine and Rehabilitation
|
December 23, 1998
Neuropathic pain in Charcot-Marie-Tooth disease
G T Carter, M P Jensen, B S Galer, et al.
Pharmacology, Biochemistry, and Behavior
|
May 26, 2023
Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression
Neil B Varshneya, Sherif H Hassanien, Melissa C Holt, et al.
The American Journal of Drug and Alcohol Abuse
|
December 1, 2001
Residential status and HIV risk behaviors among Puerto Rican drug injectors in New York and Puerto Rico
J F Andía, S Deren, S Y Kang, et al.
Page
of 22